FI840474A - Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna. - Google Patents

Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna. Download PDF

Info

Publication number
FI840474A
FI840474A FI840474A FI840474A FI840474A FI 840474 A FI840474 A FI 840474A FI 840474 A FI840474 A FI 840474A FI 840474 A FI840474 A FI 840474A FI 840474 A FI840474 A FI 840474A
Authority
FI
Finland
Prior art keywords
foerbaettringar
nizatidin
beroerande
syntes
denna
Prior art date
Application number
FI840474A
Other languages
English (en)
Finnish (fi)
Other versions
FI840474A0 (fi
Inventor
Charles Wilbur Ryan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23843341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI840474(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI840474A0 publication Critical patent/FI840474A0/fi
Publication of FI840474A publication Critical patent/FI840474A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Credit Cards Or The Like (AREA)
FI840474A 1983-02-07 1984-02-06 Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna. FI840474A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46429683A 1983-02-07 1983-02-07

Publications (2)

Publication Number Publication Date
FI840474A0 FI840474A0 (fi) 1984-02-06
FI840474A true FI840474A (fi) 1984-08-08

Family

ID=23843341

Family Applications (1)

Application Number Title Priority Date Filing Date
FI840474A FI840474A (fi) 1983-02-07 1984-02-06 Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna.

Country Status (27)

Country Link
EP (1) EP0116452B1 (US06380249-20020430-C00197.png)
JP (1) JPS59152378A (US06380249-20020430-C00197.png)
KR (1) KR860000767B1 (US06380249-20020430-C00197.png)
AT (1) ATE84530T1 (US06380249-20020430-C00197.png)
AU (1) AU559639B2 (US06380249-20020430-C00197.png)
BG (1) BG45216A3 (US06380249-20020430-C00197.png)
CA (1) CA1221369A (US06380249-20020430-C00197.png)
CS (1) CS240994B2 (US06380249-20020430-C00197.png)
DD (1) DD216459A5 (US06380249-20020430-C00197.png)
DE (1) DE3486032T2 (US06380249-20020430-C00197.png)
DK (2) DK164501C (US06380249-20020430-C00197.png)
EG (1) EG17702A (US06380249-20020430-C00197.png)
ES (1) ES529492A0 (US06380249-20020430-C00197.png)
FI (1) FI840474A (US06380249-20020430-C00197.png)
GB (1) GB2134521B (US06380249-20020430-C00197.png)
GR (1) GR81755B (US06380249-20020430-C00197.png)
HU (2) HU190527B (US06380249-20020430-C00197.png)
IE (1) IE56763B1 (US06380249-20020430-C00197.png)
IL (1) IL70880A (US06380249-20020430-C00197.png)
NZ (1) NZ207046A (US06380249-20020430-C00197.png)
PH (1) PH19941A (US06380249-20020430-C00197.png)
PL (1) PL138793B1 (US06380249-20020430-C00197.png)
PT (1) PT78063A (US06380249-20020430-C00197.png)
RO (1) RO87706A (US06380249-20020430-C00197.png)
SU (1) SU1303028A3 (US06380249-20020430-C00197.png)
UA (1) UA6020A1 (US06380249-20020430-C00197.png)
ZA (1) ZA84869B (US06380249-20020430-C00197.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
BG45216A3 (bg) 1989-04-14
PL138793B1 (en) 1986-11-29
DK51984D0 (da) 1984-02-06
IE840274L (en) 1984-08-07
DK51984A (da) 1984-08-08
ATE84530T1 (de) 1993-01-15
ES8601941A1 (es) 1985-11-01
EP0116452B1 (en) 1993-01-13
GR81755B (US06380249-20020430-C00197.png) 1984-12-12
RO87706B (ro) 1985-10-01
CS81284A2 (en) 1985-06-13
JPS59152378A (ja) 1984-08-31
KR840007591A (ko) 1984-12-08
IL70880A (en) 1987-01-30
GB2134521A (en) 1984-08-15
UA6020A1 (uk) 1994-12-29
HU194198B (en) 1988-01-28
NZ207046A (en) 1986-06-11
DK21292D0 (da) 1992-02-19
SU1303028A3 (ru) 1987-04-07
PL246097A1 (en) 1985-06-04
ZA84869B (en) 1985-09-25
PT78063A (en) 1984-03-01
EP0116452A2 (en) 1984-08-22
IL70880A0 (en) 1984-05-31
AU559639B2 (en) 1987-03-19
KR860000767B1 (ko) 1986-06-23
DE3486032D1 (de) 1993-02-25
ES529492A0 (es) 1985-11-01
PH19941A (en) 1986-08-14
AU2421584A (en) 1984-08-16
EG17702A (en) 1991-03-30
CA1221369A (en) 1987-05-05
CS240994B2 (en) 1986-03-13
FI840474A0 (fi) 1984-02-06
GB8403109D0 (en) 1984-03-07
JPH0576473B2 (US06380249-20020430-C00197.png) 1993-10-22
IE56763B1 (en) 1991-12-04
EP0116452A3 (en) 1987-04-29
HU190527B (en) 1986-09-29
RO87706A (ro) 1985-10-31
DD216459A5 (de) 1984-12-12
DK164906C (da) 1993-01-25
DK164501C (da) 1992-11-23
DK164906B (da) 1992-09-07
DK21292A (da) 1992-02-19
DK164501B (da) 1992-07-06
GB2134521B (en) 1986-10-01
DE3486032T2 (de) 1993-05-19

Similar Documents

Publication Publication Date Title
NO793076L (no) 5-(4-pyridyl-6-(4-fluorfenyl)-2,3-dihydroimidazo-(2,1-b)-tiazol
ATE21105T1 (de) 7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
GB2123830A (en) Trisubstituted diazo compounds
PT86631A (pt) Process for the preparation of a novel crystalline form of potassium clavulanate
ATE31309T1 (de) Verfahren zur herstellung von 4-hydroxy-2-methyln-2-pyridyl-2h-1,2-benzothiazin-3-carboxamid 1,1- dioxid.
FI840474A0 (fi) Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna
PL238200A1 (en) Process for preparing novel penicillins
FI874311A0 (fi) 7-/(meta-substituerade)fenylglysin/ -1-karba-1-detiakefalosporiner.
JPS52118483A (en) Nicotinylaminotriazine derivatives
JPS53120361A (en) Thyristor driver circuit
SE8104541L (sv) Sett att framstella 5-substituerade dialursyror
FR1296548A (fr) Procédé pour la préparation d'un composé de caroténoïde
JPS5283742A (en) Novel thiazole compounds
JPS527984A (en) Process for preparing thiazoline compounds by cyclization
PT91562A (pt) Process for preparing hemiphosphate hemihydrate of 2-(1-pentyl--3-guanidino-4-imidazolyl) thiazole

Legal Events

Date Code Title Description
FC Application refused

Owner name: ELI LILLY AND COMPANY